化学资讯学市场－2026-2031年预测

预计化学资讯学市场将从 2025 年的 68.17 亿美元成长到 2031 年的 149.38 亿美元，复合年增长率为 13.97%。

化学资讯学市场之所以重要，在于其作为化学、电脑科学和资讯科技交叉领域的跨领域地位。它涵盖了计算方法、软体工具和数据管理系统的开发与应用，旨在解决复杂的化学和生物学问题。化学资讯学的核心在于化学资讯的组织、分析、建模和视觉化，主要关注分子性质、结构和活性。该领域是现代研发的重要技术基础，尤其是在製药和生物技术等数据密集型产业。

推动市场扩张的根本因素是传统药物发现日益复杂且成本高昂，以及化学数据呈指数级增长。治疗方法研发，迫切需要创新，这是推动市场扩张的主要因素。化学资讯学透过实现更快、更有效率的化合物筛检、先导药物最适化以及理化和药理性质预测，直接应对了这一挑战，从而缓解并加速了早期研发流程。虚拟筛检技术的广泛应用是加速这一进程的关键。这些计算方法能够对庞大的分子库进行In Silico评估，以筛选出具有最佳性质的化合物进行合成和生物学测试，从而显着降低资源消耗和时间。

同时，对个人化医疗日益重视正成为市场发展的关键驱动因素。向标靶治疗的模式转移需要深入了解化合物在特定生物环境中的行为。化学资讯学工具对于预测药物-标靶相互作用、建立ADMET（吸收、分布、代谢、排泄、毒性）模型以及识别患者特异性先导化合物至关重要，从而支持开发更有效、更安全的个人化治疗方案。这一趋势进一步推动了对先进预测分析和数据整合平台的需求。

从区域来看，北美已确立其主导地位，成为最成熟的市场。这一主导地位得益于其强大的生态系统，包括众多大型製药和生物技术公司、持续的大规模研发投入，以及众多领先的软体供应商和学术研究中心。该地区积极采用先进的计算技术，以保持药物研发领域的竞争优势，从而巩固了其在化学资讯学领域的创新、商业性化应用和战略伙伴关係的卓越中心地位。

儘管化学资讯学市场具有巨大的变革潜力，但由于其复杂性和成本高昂，该市场仍面临许多推广障碍。其中一个关键的阻碍因素是有效利用先进的化学资讯学平台需要大量的专业知识。许多工具需要高阶计算知识，这造成了技能差距，阻碍了实验室化学家和生物学家采用这些工具。此外，整体拥有成本也是一个障碍。这不仅包括专用软体套件的授权费用，还包括对高效能运算基础设施、资料储存以及操作和解读这些先进系统所需的技术人员的大量投资。对于小规模的研究机构和学术机构而言，这些财务和技术障碍可能会限制其获取最尖端科技的机会。

竞争格局的特点是既有大型多元化生命科学技术供应商，也有专业软体公司。领先企业在整合软体平台的广度和深度上展开竞争，这些平台涵盖化学资料库管理、分子建模、动态计算和预测分析等模组。成功取决于演算法的持续创新、使用者介面设计的改进（以提高易用性），以及与实验室资讯管理系统 (LIMS) 和其他资料来源的无缝整合能力。提供强大、可扩展且合规的解决方案，进而提高科学研究效率，是企业的首要任务。

总之，化学资讯学市场是推动科学发现的重要基石，其发展与数据驱动调查方法的演进密不可分。製药业对研发效率的不懈追求以及向个人化医疗的策略转型，为化学资讯学的扩张提供了结构性支撑，而北美则扮演着重要的商业和创新中心角色。对于业内人士而言，策略重点应集中在三个方面：透过更直观的软体介面和整合的工作流程来弥合用户体验差距；透过开发基于云端的扩充性解决方案来实现用户可近性的普及；以及提升演算法能力，从而更准确地预测复杂的分子行为。成功与否取决于对终端用户科研工作流程的深刻理解，以及提供能够将海量化学数据无缝转化为可操作、可靠洞察的工具的能力，从而为研发决策提供支援。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 化学资讯学工具市场

• 介绍
• 解决方案
• 服务

第六章 按应用分類的化学资讯学市场

• 介绍
• 药物发现
• 临床研究
• 化学分析
• 其他的

第七章 按最终用户分類的化学资讯学市场

• 介绍
• 製药和生物技术公司
• 研究和学术机构
• 其他的

第八章 区域化学资讯学市场

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• BioSolveIT GmbH
• Dassault Systemes
• Certara
• Jubilant Biosys Inc.
• OpenEye Scientific（Cadence Design Systems）
• Schrodinger Inc
• Collaborative Drug Discovery Inc
• Genedata（Danaher Corporation）

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

Chemoinformatics Market is projected to expand at a 13.97% CAGR, attaining USD 14.938 billion in 2031 from USD 6.817 billion in 2025.

The chemoinformatics market is defined by its critical role as an interdisciplinary field at the nexus of chemistry, computer science, and information technology. It encompasses the development and application of computational methods, software tools, and data management systems to solve complex chemical and biological problems. At its core, chemoinformatics is concerned with the organization, analysis, modeling, and visualization of chemical information, primarily focused on the properties, structures, and activities of molecules. This discipline serves as an indispensable technological backbone for modern research and development, particularly in data-intensive sectors like pharmaceuticals and biotechnology.

Market expansion is fundamentally driven by the escalating complexity and cost of traditional drug discovery, coupled with the exponential growth of chemical data. A primary catalyst is the pressing need to innovate in therapeutic development, especially for chronic and complex diseases. Chemoinformatics directly addresses this by enabling faster, more efficient compound screening, lead optimization, and the prediction of physicochemical and pharmacological properties, thereby de-risking and accelerating the early-stage pipeline. Integral to this acceleration is the widespread adoption of virtual screening techniques. These computational methods allow for the in-silico evaluation of vast molecular libraries against biological targets, prioritizing compounds with optimal characteristics for synthesis and biological testing, which dramatically reduces resource expenditure and time.

Concurrently, the rising strategic emphasis on personalized medicine is becoming a significant market driver. The paradigm shift towards targeted therapies requires a deep understanding of compound behavior in specific biological contexts. Chemoinformatics tools are essential for predicting drug-target interactions, modeling ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) profiles, and identifying patient-specific leads, thereby supporting the development of more effective and safer tailored treatments. This trend amplifies the demand for sophisticated predictive analytics and data integration platforms.

Geographically, North America is established as the dominant and most mature market. This leadership is underpinned by a powerful ecosystem comprising major pharmaceutical and biotechnology corporations, substantial and sustained R&D investment, and a high concentration of leading software vendors and academic research centers. The region's proactive adoption of advanced computational technologies to maintain competitive advantage in drug discovery consolidates its position as the central hub for innovation, commercial deployment, and strategic partnerships in the chemoinformatics space.

Despite its transformative potential, the market faces significant adoption barriers related to complexity and cost. A primary constraint is the substantial expertise required to effectively utilize advanced chemoinformatics platforms. Many tools demand significant computational knowledge, creating a skill gap that can hinder their adoption by bench chemists and biologists. Furthermore, the total cost of ownership can be prohibitive. This includes not only the licensing fees for specialized software suites but also the significant investment in high-performance computing infrastructure, data storage, and the skilled personnel needed to operate and interpret these sophisticated systems. For smaller research organizations and academia, these financial and technical hurdles can limit access to state-of-the-art capabilities.

The competitive landscape is characterized by a mix of large, diversified life science technology providers and specialized software firms. Key players compete on the breadth and depth of their integrated software platforms, which may encompass modules for chemical database management, molecular modeling, quantum mechanics calculations, and predictive analytics. Success hinges on continuous innovation in algorithms, user interface design to improve accessibility, and the ability to integrate seamlessly with laboratory information management systems (LIMS) and other data sources. Providing robust, scalable, and compliant solutions that enhance research productivity is paramount.

In conclusion, the chemoinformatics market is a dynamic and essential enabler of scientific discovery, whose growth is inextricably linked to the evolution of data-driven research methodologies. Expansion is structurally supported by the pharmaceutical industry's relentless pursuit of R&D efficiency and the strategic pivot towards personalized medicine, with North America serving as the primary commercial and innovation center. For industry experts, strategic focus must center on bridging the usability gap through more intuitive software interfaces and integrated workflows, developing cloud-based and scalable solutions to democratize access, and advancing algorithmic capabilities for more accurate prediction of complex molecular behaviors. Success requires a deep understanding of the end-user's scientific workflow and the ability to deliver tools that seamlessly translate vast chemical data into actionable, reliable insights for decision-making in research and development.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Chemoinformatics Market Segmentation

• By Tools
• Solutions
• Services
• By Application
• Drug Discovery
• Clinical Research
• Chemical Analysis
• Others
• By End-User
• Pharmaceuticals & Biotech Companies
• Research & Academic Institutes
• Others
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CHEMOINFORMATICS MARKET BY TOOLS

• 5.1. Introduction
• 5.2. Solutions
• 5.3. Services

6. CHEMOINFORMATICS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Drug Discovery
• 6.3. Clinical Research
• 6.4. Chemical Analysis
• 6.5. Others

7. CHEMOINFORMATICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceuticals & Biotech Companies
• 7.3. Research & Academic Institutes
• 7.4. Others

8. CHEMOINFORMATICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Agilent Technologies Inc.
• 10.2. Bio-Rad Laboratories Inc.
• 10.3. BioSolveIT GmbH
• 10.4. Dassault Systemes
• 10.5. Certara
• 10.6. Jubilant Biosys Inc.
• 10.7. OpenEye Scientific (Cadence Design Systems)
• 10.8. Schrodinger Inc
• 10.9. Collaborative Drug Discovery Inc
• 10.10. Genedata (Danaher Corporation)

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations